Singapore markets closed

Teladoc Health, Inc. (TDOC)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
35.41-3.38 (-8.71%)
At close: 04:00PM EDT
35.76 +0.35 (+0.99%)
Pre-market: 08:23AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 5.72B
Enterprise value 6.43B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)2.54
Price/book (mrq)0.94
Enterprise value/revenue 2.88
Enterprise value/EBITDA -0.67

Trading information

Stock price history

Beta (5Y monthly) 0.81
52-week change 3-75.48%
S&P500 52-week change 3-7.20%
52-week high 3156.82
52-week low 327.38
50-day moving average 336.64
200-day moving average 369.12

Share statistics

Avg vol (3-month) 35.92M
Avg vol (10-day) 37.9M
Shares outstanding 5161.66M
Implied shares outstanding 6N/A
Float 8159.8M
% held by insiders 11.29%
% held by institutions 184.28%
Shares short (14 Jul 2022) 433.3M
Short ratio (14 Jul 2022) 46.24
Short % of float (14 Jul 2022) 423.45%
Short % of shares outstanding (14 Jul 2022) 420.57%
Shares short (prior month 14 Jun 2022) 436.65M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Jun 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)-9.92%

Management effectiveness

Return on assets (ttm)-1.08%
Return on equity (ttm)-89.39%

Income statement

Revenue (ttm)2.23B
Revenue per share (ttm)13.93
Quarterly revenue growth (yoy)17.70%
Gross profit (ttm)1.38B
EBITDA 4.06M
Net income avi to common (ttm)-9.87B
Diluted EPS (ttm)-43.42
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)883.7M
Total cash per share (mrq)5.47
Total debt (mrq)1.61B
Total debt/equity (mrq)26.47
Current ratio (mrq)3.38
Book value per share (mrq)37.58

Cash flow statement

Operating cash flow (ttm)220.52M
Levered free cash flow (ttm)242.73M